美容注射剤の世界市場 - 市場規模（セグメント別）、シェア、規制、償還、処置、予測（～2033年）

当レポートでは、世界の美容注射剤市場について調査分析し、主要企業と市場シェア、主要動向、革新的な製品と技術、競合情勢などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの美容注射剤と進化する競合情勢

• 主な業界動向の考察
• 美容注射剤市場のセグメント別の年間収益と市場見通し（2015年～2033年）
• セグメント別の総処置数、ユニット数、平均販売価格、市場金額に関する詳細なデータ

世界、地域、国レベルの市場固有の考察

• 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
• 美容注射剤市場のSWOT分析
• 美容注射剤市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制情勢

対象企業

• Allergan Aesthetics
• Galderma SA
• Merz Pharma GmbH & Co KgaA
• Sinclair Pharma Ltd
• Teoxane SA
• その他

Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Aesthetic Devices therapeutic area.

Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. This is achieved by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic Injectables are rising in popularity, due to the non-surgical and non-invasive nature of these procedures. In addition, successful outcomes are achieved quickly with limited recovery time.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Aesthetic Injectables and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Aesthetic Injectables market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices, and market values by segment.

Global, Regional, and Country level market specific insights -

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Aesthetic Injectables market.
• Competitive dynamics insights and trends provided for the Aesthetic Injectables market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Allergan Aesthetics, Galderma SA, Merz Pharma GmbH & Co KgaA, Sinclair Pharma Ltd, Teoxane SA, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Aesthetic Injectables marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Aesthetic Injectables market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Aesthetic Injectables market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Aesthetic Injectables market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.